Genentech

RITUXAN HYCELA

  1. Home
  2.  / 
  3. J Code
  4.  / RITUXAN HYCELA – J9311

Manufacturer:

Genentech

Name:

RITUXAN HYCELA

HCPCS Code Descriptor:

Injection, rituximab 10 mg and hyaluronidase

Category:

J Code

HCPCS:

J9311

NDC(s):

50242-0108-01, 50242-0109-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

RITUXAN HYCELA is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9311 is aligned to the drug RITUXAN HYCELA.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Inj rituximab, hyaluronidase

Billing and Coding Guide:

https://www.rituxanhycela.com/content/dam/gene/accesssolutions/pdfs/coding/Rituxan-HYCELA-Billing-Coding-for-FL.pdf

Patient Assistance:

Not Found